| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |